UNIVERSITEIT LEIDEN

Their core work

Leiden University is a top-tier Dutch research university with exceptionally broad scientific capabilities spanning life sciences, humanities, social sciences, and natural sciences. Their core strengths lie in structural biology (NMR, electron microscopy, X-ray crystallography), toxicology and drug safety, chemical biology, and social science research on migration, democracy, and societal resilience. They run large-scale research infrastructure services for the European scientific community and increasingly apply machine learning and AI to their traditional domains. With over EUR 165 million in H2020 funding across 258 projects, they function as both a fundamental research powerhouse and an infrastructure provider for translational science.

What they specialise in

How they've shifted over time

In the early H2020 period (2015–2018), Leiden focused heavily on structural biology infrastructure (NMR, EM, proteomics), metabolomics, open access infrastructure, and foundational social science research on democracy and adolescence. From 2019 onward, their profile shifted markedly toward computational methods — machine learning, deep learning, network analysis — applied to their existing domains, alongside growing work in co-creation approaches, microbiome research, glycobiology, and open science. The university has maintained its structural biology core throughout but is clearly layering data science and AI capabilities on top of its traditional wet-lab and humanities strengths.

Leiden is rapidly integrating machine learning and AI into its established life science and social science domains, making them an increasingly attractive partner for projects requiring both deep domain expertise and computational sophistication.

How they like to work

Leiden coordinates more projects than it joins as a partner (133 coordinated vs 117 as participant), which is unusual for a university and signals strong project leadership capability and administrative capacity. With 1,268 unique consortium partners across 75 countries, they operate as a major European hub rather than relying on a fixed set of repeat collaborators. Their funding scheme mix (heavy ERC, MSCA, and RIA) shows they attract both individual excellence grants and large collaborative research actions — expect a partner that can lead complex consortia but also contribute focused specialist work packages.

Leiden has built one of the largest collaboration networks in H2020, with 1,268 unique partners across 75 countries — covering virtually all EU member states plus significant global reach. This breadth reflects their multidisciplinary nature and makes them a natural connector between otherwise disconnected research communities.

What sets them apart

Leiden stands out through an unusually balanced combination of hard sciences (structural biology, chemistry, toxicology) and deep humanities/social sciences (migration, democracy, deradicalisation) — most universities of this scale skew heavily toward one or the other. Their transition from traditional lab-based methods to AI-augmented research positions them as a bridge between domain expertise and computational innovation. For consortium builders, their 51% coordination rate and 75-country network mean proven leadership and reach that few European universities can match.

Highlights from their portfolio

• EU-ToxRisk
  Largest single project (EUR 5M), coordinated by Leiden — a European flagship program for mechanism-based toxicity testing that shaped EU regulatory science.
• Crosstag
  EUR 1.5M ERC grant in chemical biology of immune cross-presentation, showcasing Leiden's frontier research in immunology at the chemistry-biology interface.
• DEMSEC
  A philosophical study of secrecy in democratic politics — exemplifies Leiden's distinctive strength in humanities research that few STEM-focused universities pursue at this funding level.